Accelerator seeks early‑stage data‑driven health ventures for five‑month programme More: Francis Crick Institute and Medicines Discovery Catapult open applications for next KQ Labs cohort Source: News
read more
EC backs first gene replacement therapy for broad sma population More: Novartis receives European Commission approval for Itvisma for spinal muscular atrophy Source: News
read moreThe ad uses hand-crafted puppets to portray sight-based frustrations for those with presbyopia, a common condition that causes blurry up-close vision. More: Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad Source:
read moreContract manufacturing powerhouse Lonza is growing in more ways than one. The Swiss company revealed this week that it is expanding its capacity to manufacture antibody-drug conjugates—and that it has increased the scope of its partnership with a large, unnamed
read moreAfter a site visit by FDA inspectors yielded a Form 483 for Genzyme Ireland in early 2026, the Sanofi subsidiary is facing further reprimand from the U.S. regulator. More: Sanofi unit in Ireland chided by FDA over manufacturing flubs linked
read more
QuantumCell gains global rights to NeuroRestore platform in deal worth over USD 2.2 billion More: AlzeCure enters collaboration agreement with QuantumCell ApS for NeuroRestore project Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals